DEF: A SPAC II Acquisition Corp. Seeks Shareholder Approval to Extend Business Combination Deadline and Expand Target Search to China

A SPAC II Acquisition Corp. is calling an Extraordinary General Meeting on July 30, 2025, to vote on extending its business combination deadline by 24 months to August 5, 2027, and to permit mergers with China-based entities, citing insufficient time to complete a deal under current terms.

Summary

• An Extraordinary General Meeting of Shareholders is scheduled for July 30, 2025, to vote on three key proposals.
• The first proposal, the Extension Amendment Proposal, seeks to amend the company's Charter to extend the deadline for consummating a business combination from August 5, 2025, to August 5, 2027, an additional 24 months.
• The company believes it will not have sufficient time to complete a business combination by the current August 5, 2025, termination date.
• The second proposal, the Target Amendment Proposal, aims to remove the current prohibition on undertaking an initial business combination with any entity having principal business operations in China (including Hong Kong and Macau), thereby expanding the pool of potential target candidates.
• The third proposal, the Adjournment Proposal, would allow the meeting to be adjourned to a later date if there are not enough votes to approve the Extension Amendment Proposal and/or the Target Amendment Proposal.
• As of July 11, 2025, the aggregate amount on deposit in the Trust Account was approximately $4.6 million, resulting in an estimated redemption price per Public Share of approximately $11.81.
• The closing price of Public Shares on the OTC on July 11, 2025, was $11.49.
• The Sponsor, A SPAC II (Holdings) Corp., does not currently plan to contribute any funds to the Trust Account to extend the current Termination Date.
• If the Extension Amendment Proposal is not approved, the company will be required to dissolve and liquidate its Trust Account by August 5, 2025, returning funds to public shareholders, while warrants and rights will expire worthless.
• Public shareholders have the right to redeem their Public Shares for cash in connection with the Extraordinary General Meeting, regardless of how they vote on the proposals, by tendering shares by July 28, 2025.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company is taking proactive steps to avoid immediate liquidation by seeking an extension and expanding its target search, the underlying reasons (insufficient time, no sponsor funding for extension) and the significant risks associated with pursuing China-based targets introduce considerable uncertainty and potential downsides for investors.

Positives

• The proposed extension provides A SPAC II Acquisition Corp. with an additional 24 months (until August 5, 2027) to identify and consummate a business combination, preventing immediate liquidation.
• Allowing business combinations with China-based targets significantly expands the pool of potential acquisition candidates, increasing the company's flexibility in finding a suitable partner.
• The Board of Directors unanimously recommends voting FOR all proposals, indicating management's belief that these actions are in the best interests of the company and its shareholders to complete a business combination.

Negatives

• The Sponsor does not plan to contribute additional funds to the Trust Account for the extension, indicating a lack of further financial commitment from the key insider.
• If the Extension Amendment Proposal is not approved, the company will be forced to liquidate by August 5, 2025, leading to warrants and rights expiring worthless.
• The current market price of Public Shares ($11.49 on July 11, 2025) is lower than the estimated redemption price ($11.81), suggesting that shareholders selling on the open market would incur a loss compared to redemption.
• The company cannot assure shareholders of sufficient liquidity to sell their Public Shares in the open market if the market price is below the redemption price.
• The interests of the Sponsor, directors, and officers in completing a business combination (to avoid their Founder Shares and Private Placement Warrants becoming worthless) may differ from those of public shareholders, potentially incentivizing a less favorable deal.

Risks

• Uncertainty regarding the ability to consummate a Business Combination even if the extension is approved and implemented.
• Potential for significant redemptions by public shareholders, which could leave insufficient cash to complete a Business Combination on commercially acceptable terms.
• Risk of being deemed an investment company under the Investment Company Act, which would impose burdensome compliance requirements and could lead to liquidation.
• If a Business Combination with a U.S. target company is pursued, it may be subject to U.S. foreign investment regulations and review by CFIUS, potentially leading to delays, conditions, or prohibition.
• If a China-based target is pursued, the company will be subject to legal and operational risks associated with changes in the legal, political, and economic policies of the Chinese government and U.S.-China relations.
• Uncertainty of interpretation and application of PRC laws and regulations, including limitations on foreign ownership in certain industries, regulatory review of overseas listings, and the validity and enforcement of Variable Interest Entity (VIE) Agreements.
• VIE structures may not be as effective as direct equity ownership, potentially incurring substantial costs to enforce terms, and nominee shareholders may not act in the best interests of the post-combined company.
• The PRC government may intervene in or influence the operations of China-based entities at any time, potentially causing material changes in business operations or affecting the value of securities.
• Potential requirement to obtain approval from Chinese authorities (CSRC, CAC) for U.S. listing or share issuance post-Business Combination, which may be denied or rescinded.
• Restrictions on transfers of cash to and from the post-combination entity due to PRC foreign exchange controls, potentially limiting dividend payments to shareholders or capital injections into PRC subsidiaries.
• Compliance with PRC Antitrust Law may delay or prevent a Business Combination.
• Risk of delisting from U.S. exchanges under the Holding Foreign Companies Accountable Act (HFCAA) if the auditor of the combined company cannot be inspected by the PCAOB for two consecutive years.
• Difficulties in enforcing civil liability against officers and directors located outside the United States, particularly in the PRC, due to lack of reciprocal recognition and enforcement of judgments.
• Increased scrutiny, criticism, and negative publicity involving U.S.-listed Chinese companies could harm business operations and reputation, potentially leading to a loss of investment.

Future Outlook

The company intends to continue its efforts to obtain approval for and consummate a Business Combination on or before the Extended Date of August 5, 2027, if the Extension Amendment Proposal is approved. A separate extraordinary general meeting will be held at a future date to approve any specific Business Combination.

Management Comments

• "The Company believes that there will not be sufficient time to consummate a Business Combination before the current Termination Date of August 5, 2025."
• "The Company needs more time to consummate the Business Combination and wants to extend the Combination Period from August 5, 2025 to August 5, 2027."
• "The Company understands that its sponsor, A SPAC II (Holdings) Corp. (the Sponsor), does not currently plan to contribute any fund to the Trust Account to extend the Companys current Termination Date."
• "The Board has determined that given the Companys expenditure of time, efforts and money on identifying suitable target business and completion of a Business Combination, and the market opportunity the Company has observed in the Peoples Republic of China (including Hong Kong and Macau) (the PRC, or China), it is in the best interests of its shareholder to approve the Target Amendment Proposal."
• "The Board unanimously recommends that you vote or give instruction to vote FOR such proposals."

Industry Context

This proxy statement reflects a common challenge faced by Special Purpose Acquisition Companies (SPACs) in the current market environment: the difficulty of identifying and completing a suitable business combination within the initial timeframe. The proposal to extend the deadline is a frequent occurrence for SPACs nearing their termination date. The decision to expand the target search to include China-based entities also highlights the evolving landscape for SPACs, particularly given the increased regulatory scrutiny and geopolitical tensions surrounding Chinese companies seeking to list or operate in the U.S. market, as evidenced by the detailed risks related to CFIUS, PCAOB, and PRC regulations.

Comparison to Industry Standards

• NA

Corporate Governance

Related Party Transactions

• The document discusses the requirement for approval of future related party transactions by disinterested directors, but does not disclose any specific current related party dealings beyond the Sponsor's ownership and the management's interests in the Founder Shares and Private Placement Warrants.

Stakeholder Impact

• **Shareholders (Public Shares):** Face a decision between redeeming their shares for a pro rata portion of the Trust Account (approximately $11.81 per share) or holding them in the hope of a future business combination, which now carries extended timeline and new geographic risks. Their warrants and rights will expire worthless if the company liquidates.
• **Sponsor and Initial Shareholders:** Have a strong incentive to see a business combination completed, as their Founder Shares (acquired for $25,000, valued at ~$57.5 million) and Private Placement Warrants (acquired for $8,966,000, valued at ~$89,660) will become worthless if no deal is consummated by the extended deadline. Their interests may diverge from public shareholders.
• **Management and Directors:** Their continued involvement and potential future compensation are tied to the successful completion of a business combination. They are reimbursed for out-of-pocket expenses related to identifying and consummating a business combination.

Next Steps

• Shareholders are urged to read the Proxy Statement and vote by submitting a proxy or voting instructions prior to the Extraordinary General Meeting.
• Shareholders wishing to redeem their Public Shares must submit a written request and deliver shares to the transfer agent by July 28, 2025.
• If the Extension Amendment Proposal is approved, the company will file the fourth amended and restated memorandum and articles of association with the British Virgin Islands Registrar of Corporate Affairs.
• If the Extension Amendment Proposal and Target Amendment Proposal are adopted, the company will continue to attempt to consummate a Business Combination until the Extended Date (August 5, 2027).
• A separate extraordinary general meeting will be held at a later date for shareholders to vote on any proposed Business Combination.

Key Dates

Recommendation

Keywords

SPAC, Special Purpose Acquisition Company, Business Combination, Extension, China Target, SEC Filing, Proxy Statement, Liquidation, Redemption, Trust Account, Corporate Governance, Risk Management, CFIUS, PCAOB, VIE Structure, PRC Regulations, Shareholder Vote